Published in Biochemistry on June 10, 1980
Activation of acetylcholine receptors on clonal mammalian BC3H-1 cells by high concentrations of agonist. J Physiol (1987) 3.84
Desensitization at the frog neuromuscular junction: a biphasic process. J Physiol (1982) 2.31
Substance P reduces acetylcholine-induced currents in isolated bovine chromaffin cells. J Physiol (1984) 2.09
Kinetic parameters for acetylcholine interaction in intact neuromuscular junction. Proc Natl Acad Sci U S A (1981) 2.05
d-Tubocurarine binding sites are located at alpha-gamma and alpha-delta subunit interfaces of the nicotinic acetylcholine receptor. Proc Natl Acad Sci U S A (1990) 1.78
Acetylcholine receptor channel structure in the resting, open, and desensitized states probed with the substituted-cysteine-accessibility method. Proc Natl Acad Sci U S A (2001) 1.73
The multiple phenotypes of allosteric receptor mutants. Proc Natl Acad Sci U S A (1996) 1.57
Mouse-Torpedo hybrid acetylcholine receptors: functional homology does not equal sequence homology. Proc Natl Acad Sci U S A (1985) 1.46
Acetylcholine-induced cation translocation across cell membranes and inactivation of the acetylcholine receptor: chemical kinetic measurements in the millisecond time region. Proc Natl Acad Sci U S A (1981) 1.46
Nicotinic postsynaptic membranes from Torpedo: sidedness, permeability to macromolecules, and topography of major polypeptides. J Cell Biol (1982) 1.27
The intrinsic energy of the gating isomerization of a neuromuscular acetylcholine receptor channel. J Gen Physiol (2012) 1.25
Poisson-distributed active fusion complexes underlie the control of the rate and extent of exocytosis by calcium. J Cell Biol (1996) 1.06
Activation and desensitization of Torpedo acetylcholine receptor: evidence for separate binding sites. Proc Natl Acad Sci U S A (1982) 1.04
Temperature and end-plate currents in rat diaphragm. J Physiol (1983) 0.99
Specific reaction rate of acetylcholine receptor-controlled ion translocation: a comparison of measurements with membrane vesicles and with muscle cells. Proc Natl Acad Sci U S A (1981) 0.98
Time-resolved photolabeling by the noncompetitive blocker chlorpromazine of the acetylcholine receptor in its transiently open and closed ion channel conformations. Proc Natl Acad Sci U S A (1984) 0.96
Desensitization contributes to the synaptic response of gain-of-function mutants of the muscle nicotinic receptor. J Gen Physiol (2006) 0.96
Functional stoichiometry at the nicotinic receptor. The photon cross section for phase 1 corresponds to two bis-Q molecules per channel. J Gen Physiol (1982) 0.94
Fast desensitization of the nicotinic receptor at the mouse neuromuscular junction. Br J Pharmacol (1982) 0.92
Measuring relative acetylcholine receptor agonist binding by selective proton nuclear magnetic resonance relaxation experiments. Biophys J (1988) 0.92
Comparison of acetylcholine receptor-controlled cation flux in membrane vesicles from Torpedo californica and Electrophorus electricus: chemical kinetic measurements in the millisecond region. Proc Natl Acad Sci U S A (1982) 0.90
Modeling nicotinic neuromodulation from global functional and network levels to nAChR based mechanisms. Acta Pharmacol Sin (2009) 0.89
Two-component desensitization of nicotinic receptors induced by acetylcholine agonists in Lymnaea stagnalis neurones. J Physiol (1984) 0.87
High acetylcholine concentrations cause rapid inactivation before fast desensitization in nicotinic acetylcholine receptors from Torpedo. Biophys J (1988) 0.84
Estimation of ligand affinity constants for receptor states in functional studies involving the allosteric modulation of G protein-coupled receptors: implications for ligand bias. J Pharmacol Toxicol Methods (2014) 0.81
Allosteric regulation of pentameric ligand-gated ion channels: an emerging mechanistic perspective. Channels (Austin) (2014) 0.80
Protein dynamics and the allosteric transitions of pentameric receptor channels. Biophys Rev (2014) 0.79
Intermediate closed state for glycine receptor function revealed by cysteine cross-linking. Proc Natl Acad Sci U S A (2013) 0.78
Stoichiometry for α-bungarotoxin block of α7 acetylcholine receptors. Nat Commun (2015) 0.77
The concept of allosteric interaction and its consequences for the chemistry of the brain. J Biol Chem (2013) 0.77
Transmembrane flux and receptor desensitization measured with membrane vesicles. Homogeneity of vesicles investigated by computer simulation. Biophys J (1988) 0.75
Modes of hexamethonium action on acetylcholine receptor channels in frog skeletal muscle. Br J Pharmacol (1991) 0.75
Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: prevalence of coronary and hypertensive heart disease and associated risk factors. Am J Epidemiol (1975) 3.26
Acetylcholine and local anesthetic binding to Torpedo nicotinic postsynaptic membranes after removal of nonreceptor peptides. Proc Natl Acad Sci U S A (1979) 2.62
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Diversity of germ-line immunoglobulin VH genes. Nature (1981) 2.47
Isolation of AIDS-associated retrovirus from genital secretions of women with antibodies to the virus. Lancet (1986) 2.43
Activation of the c-mos oncogene in a mouse plasmacytoma by insertion of an endogenous intracisternal A-particle genome. Proc Natl Acad Sci U S A (1983) 2.23
Simple DNA sequences in homologous flanking regions near immunoglobulin VH genes: a role in gene interaction? Nucleic Acids Res (1982) 2.19
Organization and evolution of immunoglobulin VH gene subgroups. Proc Natl Acad Sci U S A (1982) 2.18
Purification from Torpedo marmorata electric tissue of membrane fragments particularly rich in cholinergic receptor protein. FEBS Lett (1972) 2.09
Presence of a lattice structure in membrane fragments rich in nicotinic receptor protein from the electric organ of Torpedo marmorata. FEBS Lett (1973) 2.03
Identifying the lipid-protein interface of the Torpedo nicotinic acetylcholine receptor: secondary structure implications. Biochemistry (1994) 1.98
Equilibrium binding of [3H]tubocurarine and [3H]acetylcholine by Torpedo postsynaptic membranes: stoichiometry and ligand interactions. Biochemistry (1979) 1.83
d-Tubocurarine binding sites are located at alpha-gamma and alpha-delta subunit interfaces of the nicotinic acetylcholine receptor. Proc Natl Acad Sci U S A (1990) 1.78
Immunofluorescence localization at the mammalian neuromuscular junction of the Mr 43,000 protein of Torpedo postsynaptic membranes. Proc Natl Acad Sci U S A (1981) 1.72
Regulator of G protein signaling proteins: novel multifunctional drug targets. J Pharmacol Exp Ther (2001) 1.66
Rearrangement of the oncogene c-mos in mouse myeloma NSI and hybridomas. Nature (1984) 1.66
STUDIES IN ANTISEPTICS (II): ON CHLORAMINE: ITS PREPARATION, PROPERTIES, AND USE. Br Med J (1916) 1.65
A point mutation in Galphao and Galphai1 blocks interaction with regulator of G protein signaling proteins. J Biol Chem (1998) 1.60
"Retroposon" insertion into the cellular oncogene c-myc in canine transmissible venereal tumor. Proc Natl Acad Sci U S A (1985) 1.56
Mapping of the acetylcholine binding site of the nicotinic acetylcholine receptor: [3H]nicotine as an agonist photoaffinity label. Biochemistry (1991) 1.54
Conformations of Torpedo acetylcholine receptor associated with ion transport and desensitization. Biochemistry (1982) 1.52
Fluorescent BODIPY-GTP analogs: real-time measurement of nucleotide binding to G proteins. Anal Biochem (2001) 1.50
Prevalence and significance of acanthosis nigricans in an adult obese population. Arch Dermatol (1992) 1.49
Survival for women and men with AIDS. J Infect Dis (1992) 1.49
Phenotypic heterogeneity associated with the splicing mutation in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab (1996) 1.46
Seroprevalence and risk factors for HTLV-I/II infection among female prostitutes in the United States. JAMA (1990) 1.43
The 87K postsynaptic membrane protein from Torpedo is a protein-tyrosine kinase substrate homologous to dystrophin. Neuron (1993) 1.32
Agonist-induced changes in the structure of the acetylcholine receptor M2 regions revealed by photoincorporation of an uncharged nicotinic noncompetitive antagonist. J Biol Chem (1992) 1.31
Kinetics of binding of [3H]acetylcholine to Torpedo postsynaptic membranes: association and dissociation rate constants by rapid mixing and ultrafiltration. Biochemistry (1980) 1.30
Identification of sites of incorporation in the nicotinic acetylcholine receptor of a photoactivatible general anesthetic. J Biol Chem (2000) 1.30
Guanine nucleotide effects on catecholamine secretion from digitonin-permeabilized adrenal chromaffin cells. J Biol Chem (1986) 1.28
Cloning and characterization of the human homologue of a dystrophin related phosphoprotein found at the Torpedo electric organ post-synaptic membrane. Hum Mol Genet (1996) 1.28
Nicotinic postsynaptic membranes from Torpedo: sidedness, permeability to macromolecules, and topography of major polypeptides. J Cell Biol (1982) 1.27
Molecular cloning and characterization of a novel regulator of G-protein signaling from mouse hematopoietic stem cells. J Biol Chem (2001) 1.27
Identification of a local anesthetic binding site in nicotinic post-synaptic membranes isolated from Torpedo marmorata electric tissue. Mol Pharmacol (1979) 1.24
Location of ligand-binding sites on the nicotinic acetylcholine receptor alpha-subunit. J Biol Chem (1986) 1.22
Kinetics of binding of [3H]acetylcholine and [3H]carbamoylcholine to Torpedo postsynaptic membranes: slow conformational transitions of the cholinergic receptor. Biochemistry (1980) 1.22
Mapping the lipid-exposed regions in the Torpedo californica nicotinic acetylcholine receptor. Biochemistry (1992) 1.21
Mechanism of nicotinic acetylcholine receptor cluster formation by rapsyn. Proc Natl Acad Sci U S A (1998) 1.20
Role of rapsyn tetratricopeptide repeat and coiled-coil domains in self-association and nicotinic acetylcholine receptor clustering. J Biol Chem (2000) 1.19
Contributions of Torpedo nicotinic acetylcholine receptor gamma Trp-55 and delta Trp-57 to agonist and competitive antagonist function. J Biol Chem (2000) 1.19
U1 snRNA promotes the selection of nearby 5' splice sites by U6 snRNA in mammalian cells. Genes Dev (1996) 1.17
Polymorphism of germ-line immunoglobulin VH genes correlates with allotype and idiotype markers. Eur J Immunol (1981) 1.17
Structure of the noncompetitive antagonist-binding site of the Torpedo nicotinic acetylcholine receptor. [3H]meproadifen mustard reacts selectively with alpha-subunit Glu-262. J Biol Chem (1992) 1.14
Rapid kinetics of regulator of G-protein signaling (RGS)-mediated Galphai and Galphao deactivation. Galpha specificity of RGS4 AND RGS7. J Biol Chem (2000) 1.14
Identification of tryptophan 55 as the primary site of [3H]nicotine photoincorporation in the gamma-subunit of the Torpedo nicotinic acetylcholine receptor. FEBS Lett (1998) 1.13
The cholinergic receptor protein in its membrane environment. Annu Rev Pharmacol (1975) 1.12
THE ANTISEPTIC PROPERTIES OF CYANINE DYES. Br Med J (1922) 1.12
Identification of amino acids contributing to high and low affinity d-tubocurarine sites in the Torpedo nicotinic acetylcholine receptor. J Biol Chem (1997) 1.11
Conservation and divergence of immunoglobulin VH pseudogenes. EMBO J (1983) 1.10
Desensitization of membrane-bound Torpedo acetylcholine receptor by amine noncompetitive antagonists and aliphatic alcohols: studies of [3H]acetylcholine binding and 22Na+ ion fluxes. Biochemistry (1984) 1.10
Interactions of the rapsyn RING-H2 domain with dystroglycan. J Biol Chem (2001) 1.09
Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications. Gene Ther (1998) 1.08
Effect of palytoxin on membrane and potential and current of frog myelinated fibers. J Pharmacol Exp Ther (1977) 1.08
Mapping the agonist binding site of the nicotinic acetylcholine receptor. Orientation requirements for activation by covalent agonist. J Biol Chem (2000) 1.08
Fluorescent guanine nucleotide analogs and G protein activation. J Biol Chem (1994) 1.07
A novel 87,000-Mr protein associated with acetylcholine receptors in Torpedo electric organ and vertebrate skeletal muscle. J Cell Biol (1989) 1.07
Determinants of gi1alpha and beta gamma binding. Measuring high affinity interactions in a lipid environment using flow cytometry. J Biol Chem (1998) 1.06
Association of the Mr 58,000 postsynaptic protein of electric tissue with Torpedo dystrophin and the Mr 87,000 postsynaptic protein. J Biol Chem (1992) 1.06
Photolabeling of membrane-bound Torpedo nicotinic acetylcholine receptor with the hydrophobic probe 3-trifluoromethyl-3-(m-[125I]iodophenyl)diazirine. Biochemistry (1988) 1.05
Timing is everything the role of kinetics in G protein activation. Life Sci (2000) 1.05
Analysis of guanine nucleotide binding and exchange kinetics of the Escherichia coli GTPase Era. J Bacteriol (2000) 1.05
Walker A lysine mutations of TAP1 and TAP2 interfere with peptide translocation but not peptide binding. J Biol Chem (2000) 1.04
Novel form of crosstalk between G protein and tyrosine kinase pathways. Proc Natl Acad Sci U S A (1997) 1.03
Base pairing at the 5' splice site with U1 small nuclear RNA promotes splicing of the upstream intron but may be dispensable for slicing of the downstream intron. Mol Cell Biol (1996) 1.02
The steroid promegestone is a noncompetitive antagonist of the Torpedo nicotinic acetylcholine receptor that interacts with the lipid-protein interface. Mol Pharmacol (1999) 1.02
Meproadifen reaction with the ionic channel of the acetylcholine receptor: potentiation of agonist-induced desensitization at the frog neuromuscular junction. Mol Pharmacol (1982) 1.01
Childhood cultural experience and the incidence of coronary heart disease in Hawaii Japanese men. Am J Epidemiol (1979) 1.01
Allelic immunoglobulin VH genes in two mouse strains: possible germline gene recombination. EMBO J (1983) 1.00
Receptor and membrane interaction sites on Gbeta. A receptor-derived peptide binds to the carboxyl terminus. J Biol Chem (1996) 0.99
Photoaffinity labeling the torpedo nicotinic acetylcholine receptor with [(3)H]tetracaine, a nondesensitizing noncompetitive antagonist. Mol Pharmacol (1999) 0.99
Visualization of the cytoplasmic surface of Torpedo postsynaptic membranes by freeze-etch and immunoelectron microscopy. J Cell Biol (1987) 0.99
Pseudotyping of glycoprotein D-deficient herpes simplex virus type 1 with vesicular stomatitis virus glycoprotein G enables mutant virus attachment and entry. J Virol (2000) 0.98
Identification of amino acids of the torpedo nicotinic acetylcholine receptor contributing to the binding site for the noncompetitive antagonist [(3)H]tetracaine. Mol Pharmacol (1999) 0.98
Binding of an alpha 2 adrenergic receptor third intracellular loop peptide to G beta and the amino terminus of G alpha. J Biol Chem (1994) 0.98
Penile Kaposi's sarcoma preceded by chronic penile lymphoedema. Br J Dermatol (2000) 0.97
Ectopic matrix metalloproteinase-9 expression in human brain tumor cells enhances oncolytic HSV vector infection. Gene Ther (2010) 0.97
Agonist and antagonist binding to alpha 2-adrenergic receptors in purified membranes from human platelets. Implications of receptor-inhibitory nucleotide-binding protein stoichiometry. Mol Pharmacol (1985) 0.97
Double suicide gene therapy using a replication defective herpes simplex virus vector reveals reciprocal interference in a malignant glioma model. Gene Ther (2002) 0.97
Interdomain interactions regulate GDP release from heterotrimeric G proteins. Biochemistry (1999) 0.96
The 43-kilodalton protein of Torpedo nicotinic postsynaptic membranes: purification and determination of primary structure. Biochemistry (1987) 0.95
Acetylcholine receptor-associated 43K protein contains covalently bound myristate. J Cell Biol (1988) 0.95
X-ray diffraction study of membrane fragments rich in acetylcholine receptor protein prepared from the electric organ of Torpedo marmorata. FEBS Lett (1974) 0.95
Probing the structure of the nicotinic acetylcholine receptor ion channel with the uncharged photoactivable compound -3H-diazofluorene. J Biol Chem (1998) 0.95
Roles of G(o)alpha tryptophans in GTP hydrolysis, GDP release, and fluorescence signals. Biochemistry (1998) 0.94
Hereditary hypodontia and onychorrhexis of the fingernails and toenail koilonychia: Witkop's tooth-and nail syndrome. Dermatol Online J (1999) 0.94
Agonist-directed trafficking of porcine alpha(2A)-adrenergic receptor signaling in Chinese hamster ovary cells: l-isoproterenol selectively activates G(s). J Pharmacol Exp Ther (2000) 0.94
The novel alpha-2 adrenergic radioligand [3H]-MK912 is alpha-2C selective among human alpha-2A, alpha-2B and alpha-2C adrenoceptors. J Pharmacol Exp Ther (1994) 0.94
U1 small nuclear RNA-promoted exon selection requires a minimal distance between the position of U1 binding and the 3' splice site across the exon. Mol Cell Biol (1997) 0.94
Multiple Gi protein subtypes regulate a single effector mechanism. Mol Pharmacol (1991) 0.94
HIV-related oral manifestations in two cohorts of women in San Francisco. J Acquir Immune Defic Syndr (1994) 0.93
Structure and activity of the translocated c-myc in mouse plasmacytoma XRPC-24. Gene (1986) 0.93
The hydrophobic photoreagent 3-(trifluoromethyl)-3-m-([125I] iodophenyl) diazirine is a novel noncompetitive antagonist of the nicotinic acetylcholine receptor. J Biol Chem (1991) 0.93
Receptor-G protein gamma specificity: gamma11 shows unique potency for A(1) adenosine and 5-HT(1A) receptors. Biochemistry (2001) 0.93
Membrane reconstitution of high-affinity alpha 2 adrenergic agonist binding with guanine nucleotide regulatory proteins. Biochemistry (1987) 0.92
Synthesis and properties of 3-(2-hydroxyethyl)-3-n-pentyldiazirine, a photoactivable general anesthetic. J Med Chem (1999) 0.92